Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119409694 | 11940969 | 4 | F | 20160413 | 20160621 | 20160122 | 20160704 | EXP | BR-PFIZER INC-2016024010 | PFIZER | 45.00 | YR | M | Y | 53.00000 | KG | 20160704 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119409694 | 11940969 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, ONCE A DAY CYCLIC 4X2 (SING 28 DAYS, PAUSING 14) | Y | Z597A | 21938 | 50 | MG | CAPSULE, HARD | |||||
| 119409694 | 11940969 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Y | 21938 | CAPSULE, HARD | ||||||||||
| 119409694 | 11940969 | 3 | C | NYSTATIN. | NYSTATIN | 1 | 0 | ||||||||||||
| 119409694 | 11940969 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 119409694 | 11940969 | 5 | C | DECADRON | DEXAMETHASONE | 1 | 4MG/DAY | 0 | 4 | MG | |||||||||
| 119409694 | 11940969 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 1 TABLET AT NIGHT | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119409694 | 11940969 | 1 | Metastatic renal cell carcinoma |
| 119409694 | 11940969 | 2 | Neoplasm malignant |
| 119409694 | 11940969 | 3 | Wound |
| 119409694 | 11940969 | 6 | Blood cholesterol |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119409694 | 11940969 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119409694 | 11940969 | Asthenia | |
| 119409694 | 11940969 | Blood potassium decreased | |
| 119409694 | 11940969 | Blood sodium decreased | |
| 119409694 | 11940969 | Blood zinc decreased | |
| 119409694 | 11940969 | Disease progression | |
| 119409694 | 11940969 | Ear infection | |
| 119409694 | 11940969 | Eating disorder | |
| 119409694 | 11940969 | Epistaxis | |
| 119409694 | 11940969 | Fall | |
| 119409694 | 11940969 | Feeling abnormal | |
| 119409694 | 11940969 | Gastrooesophageal reflux disease | |
| 119409694 | 11940969 | Haemoglobin decreased | |
| 119409694 | 11940969 | Metastatic renal cell carcinoma | |
| 119409694 | 11940969 | Mouth injury | |
| 119409694 | 11940969 | Nausea | |
| 119409694 | 11940969 | Skin discolouration | |
| 119409694 | 11940969 | Tympanic membrane perforation | |
| 119409694 | 11940969 | Vomiting | |
| 119409694 | 11940969 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119409694 | 11940969 | 1 | 201508 | 0 | ||
| 119409694 | 11940969 | 4 | 201508 | 0 | ||
| 119409694 | 11940969 | 5 | 201508 | 0 | ||
| 119409694 | 11940969 | 6 | 201602 | 0 |